Repeated Orotracheal Intubation in Mice
March 27th, 2020
20.4K views
The goal of this article is to describe a refined method of intubation of the laboratory mouse. The method is noninvasive and, therefore, ideal for studies that require serial monitoring of respiratory function and/or instillation of treatments into the lung.
Overview
This article describes a refined, noninvasive method for intubating laboratory mice, suitable for studies requiring serial monitoring of respiratory function. The protocol allows for repeat measurements of lung function, minimizing experimental variability.
Key Study Components
Area of Science
- Neuroscience
- Respiratory physiology
- Laboratory animal techniques
Background
- Intubation is critical for studies involving lung function.
- Traditional methods may involve invasive techniques.
- Noninvasive approaches can enhance animal welfare.
- Understanding trachea identification is essential for this method.
Purpose of Study
- To provide a refined intubation technique for laboratory mice.
- To facilitate serial monitoring of respiratory function.
- To reduce the number of mice needed for experiments.
Methods Used
- Noninvasive intubation technique demonstrated visually.
- Use of a 15 to 20-centimeter length of 3-0 silk for intubation platform.
- Collaboration with a veterinarian for technique demonstration.
- Focus on identifying the trachea through the skin of the ventral neck.
Main Results
- Successful intubation without visualization of the trachea through the oral cavity.
- Reduced variability in lung function measurements.
- Enhanced ability to study chronic lung diseases.
- Demonstrated technique improves experimental outcomes.
Conclusions
- The refined intubation method is effective and noninvasive.
- This protocol is valuable for researchers studying respiratory diseases.
- Visual demonstration is crucial for proper technique execution.
Frequently Asked Questions
What is the main advantage of this intubation method?
The main advantage is that it is noninvasive, allowing for serial monitoring without the need for traumatic dissection.
Who demonstrates the intubation technique?
The technique is demonstrated by Kate Nolan, a veterinarian from the laboratory.
What diseases can this method help study?
It is particularly useful for studying chronic lung diseases such as asthma, COPD, emphysema, and pulmonary fibrosis.
How does this method reduce the number of mice needed?
By allowing repeat measurements of lung function in individual mice, it decreases the overall number required for experiments.
What materials are needed for the intubation platform?
A 15 to 20-centimeter length of 3-0 silk and a three-inch three-ring binder are needed to create the platform.
Is visualization of the trachea necessary for this method?
No, this method does not require visualization of the trachea through the oral cavity.
Executive Industry Relevance
This method enables repeated, noninvasive intubation in mice, supporting longitudinal assessment of lung function in preclinical respiratory disease models. By reducing procedural trauma and experimental variability, it enhances data reliability and decreases animal usage in chronic disease studies. The approach improves target validation confidence by allowing consistent compound exposure and functional readouts across multiple time points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through serial lung function measurements in individual mice.
- Operational Value: Reduces biological variability by eliminating intubation-related trauma between time points.
- Predictive Value: Supports mechanistic de-risking by providing stable baselines for assessing compound effects on respiratory parameters.
Screening & Assay Development
- Assay Readiness: Prepares validated biological systems for compound instillation and functional respiratory assessment.
- Quantitative Output: Facilitates reproducible measurements of respiratory resistance via forced oscillation technique.
- Scalability: Enables platform reuse across multiple time points, supporting dose-response and longitudinal screening designs.
Translational & Preclinical Research
- Disease Relevance: Directly applicable to modeling chronic progressive lung diseases such as asthma, COPD, emphysema, and pulmonary fibrosis.
- Translational Continuity: Bridges discovery and preclinical validation by enabling consistent target engagement monitoring.
- Risk-Adjusted Decisions: Improves confidence in go/no-go criteria by reducing noise from procedural artifacts.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from early target validation through lead optimization to preclinical efficacy testing, particularly for respiratory indications where serial lung function is a key biomarker.
- Discovery Biology: Supports hypothesis testing by enabling repeated assessment of target-mediated physiological changes.
- Screening: Enhances assay reliability through standardized, repeatable intubation without tissue damage.
- Analytics: Generates quantitative respiratory resistance measurements that allow inter-condition comparison and effect size calculation.
- Translational Research: Aligns with biomarker-driven advancement by providing functional readouts relevant to human respiratory pathology.
- Enterprise Reuse: Establishes a reusable intubation capability across multiple projects and disease models requiring chronic lung monitoring.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence by minimizing confounding variables from intubation trauma.
- Operational Value: Improves standardization and reproducibility across laboratories and study timelines.
- Strategic Value: Enhances capital efficiency by reducing animal numbers and increasing statistical power per subject.
- Portfolio Impact: Enables risk-adjusted prioritization through more reliable longitudinal data on target modulation and safety.
Implementation Considerations
- Requires training in ventral neck trachea identification and cannula manipulation techniques.
- Depends on basic instrumentation including intubation platform, cannula, ventilator adapter, and lung inflation bulb.
- Necessitates cross-team standardization of depilatory application, skin preparation, and cannula advancement protocols.
- Adaptation considerations include adjustments for mouse strain, age, and body weight affecting trachea visibility and cannula sizing.
- Practical limitations include dependency on operator skill for consistent transcutaneous visualization and cannula placement.
Biopharma FAQs
Why does avoiding tracheal visualization through the oral cavity matter for target validation?
Avoiding oral visualization reduces tissue trauma and variability, improving the reliability of repeated lung function measurements used to validate respiratory targets across multiple time points.
How does independent variable isolation improve discovery pipeline confidence?
By standardizing intubation and minimizing procedural artifacts, the method isolates the effect of compounds or genetic modifications on lung function, increasing confidence in target engagement data.
What quantitative dependent variable measurements enable preclinical decision-making?
Forced oscillation technique-derived respiratory resistance measurements provide quantifiable, repeatable endpoints for assessing compound effects and disease progression in individual mice.
Why do replication requirements matter for cross-functional collaboration in respiratory studies?
Replication across time points in the same animal reduces inter-subject variability, enabling consistent data sharing between discovery, toxicology, and translational teams.
What statistical analysis capabilities are required before implementing this intubation method?
Baseline variability assessment and power analysis are needed to determine sufficient replication levels for detecting meaningful changes in respiratory resistance over time.
